PortfoliosLab logoPortfoliosLab logo
0B2.DE vs. RMD
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

0B2.DE vs. RMD - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in BAWAG Group AG (0B2.DE) and ResMed Inc. (RMD). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

0B2.DE is traded in EUR, while RMD is traded in USD. To make them comparable, the RMD values have been converted to EUR using the latest available exchange rates.

Returns By Period

In the year-to-date period, 0B2.DE achieves a 23.06% return, which is significantly higher than RMD's -17.97% return.


0B2.DE

1D
2.92%
1M
4.04%
YTD
23.06%
6M
34.68%
1Y
46.26%
3Y*
62.56%
5Y*
35.83%
10Y*

RMD

1D
4.07%
1M
-5.62%
YTD
-17.97%
6M
-22.12%
1Y
-22.81%
3Y*
-5.99%
5Y*
0.71%
10Y*
13.52%
*Multi-year figures are annualized to reflect compound growth (CAGR)

0B2.DE vs. RMD - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
0B2.DE
BAWAG Group AG
23.06%70.86%82.66%6.44%-1.75%40.29%-5.03%9.08%-12.76%
RMD
ResMed Inc.
-17.97%-6.35%43.04%-19.05%-14.48%32.64%26.93%40.96%22.30%

Correlation

The correlation between 0B2.DE and RMD is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.07

Correlation (3Y)
Calculated over the trailing 3-year period

0.01

Correlation (5Y)
Calculated over the trailing 5-year period

0.01

Correlation (All Time)
Calculated using the full available price history since May 8, 2018

0.02

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

0B2.DE vs. RMD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

0B2.DE
0B2.DE Risk / Return Rank: 8383
Overall Rank
0B2.DE Sharpe Ratio Rank: 8585
Sharpe Ratio Rank
0B2.DE Sortino Ratio Rank: 8181
Sortino Ratio Rank
0B2.DE Omega Ratio Rank: 7979
Omega Ratio Rank
0B2.DE Calmar Ratio Rank: 8383
Calmar Ratio Rank
0B2.DE Martin Ratio Rank: 8787
Martin Ratio Rank

RMD
RMD Risk / Return Rank: 1111
Overall Rank
RMD Sharpe Ratio Rank: 77
Sharpe Ratio Rank
RMD Sortino Ratio Rank: 99
Sortino Ratio Rank
RMD Omega Ratio Rank: 1010
Omega Ratio Rank
RMD Calmar Ratio Rank: 2121
Calmar Ratio Rank
RMD Martin Ratio Rank: 99
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

0B2.DE vs. RMD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for BAWAG Group AG (0B2.DE) and ResMed Inc. (RMD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


0B2.DERMDDifference
Sharpe ratioReturn per unit of total volatility

+2.71

Sortino ratioReturn per unit of downside risk

+3.64

Omega ratioGain probability vs. loss probability

1.30

0.85

+0.46

Calmar ratioReturn relative to maximum drawdown

3.01

-0.62

+3.63

Martin ratioReturn relative to average drawdown

10.04

-1.46

+11.50

0B2.DE vs. RMD - Sharpe Ratio Comparison

The current 0B2.DE Sharpe Ratio is 1.74, which is higher than the RMD Sharpe Ratio of -0.97. The chart below compares the historical Sharpe Ratios of 0B2.DE and RMD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


0B2.DERMDDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.74

-0.97

+2.71

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

1.45

0.02

+1.42

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.43

Sharpe Ratio (All Time)

Calculated using the full available price history

0.95

0.48

+0.47

Drawdowns

0B2.DE vs. RMD - Drawdown Comparison

The maximum 0B2.DE drawdown since its inception was -53.63%, which is greater than RMD's maximum drawdown of -48.54%. Use the drawdown chart below to compare losses from any high point for 0B2.DE and RMD.


Loading charts...

Drawdown Indicators


0B2.DERMDDifference

Max Drawdown

Largest peak-to-trough decline

-53.63%

-48.54%

-5.09%

Max Drawdown (1Y)

Largest decline over 1 year

-15.89%

-36.99%

+21.10%

Max Drawdown (3Y)

Largest decline over 3 years

-19.84%

-38.44%

+18.60%

Max Drawdown (5Y)

Largest decline over 5 years

-30.88%

-48.54%

+17.66%

Max Drawdown (10Y)

Largest decline over 10 years

-48.54%

Current Drawdown

Current decline from peak

-2.19%

-32.93%

+30.74%

Average Drawdown

Average peak-to-trough decline

-10.33%

-13.46%

+3.13%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.73%

15.63%

-10.90%

Volatility

0B2.DE vs. RMD - Volatility Comparison

The current volatility for BAWAG Group AG (0B2.DE) is 7.37%, while ResMed Inc. (RMD) has a volatility of 10.56%. This indicates that 0B2.DE experiences smaller price fluctuations and is considered to be less risky than RMD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


0B2.DERMDDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.37%

10.56%

-3.19%

Volatility (6M)

Calculated over the trailing 6-month period

21.15%

19.42%

+1.73%

Volatility (1Y)

Calculated over the trailing 1-year period

27.45%

23.61%

+3.84%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

33.31%

30.75%

+2.56%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

41.10%

31.67%

+9.43%

Dividends

0B2.DE vs. RMD - Dividend Comparison

0B2.DE's dividend yield for the trailing twelve months is around 4.12%, more than RMD's 1.24% yield.


PositionTTM20252024202320222021202020192018201720162015
0B2.DE
BAWAG Group AG
4.12%4.28%6.21%7.69%6.11%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
RMD
ResMed Inc.
1.24%0.94%0.88%1.07%0.83%0.62%0.73%0.98%1.26%1.61%2.03%2.16%

Financials

0B2.DE vs. RMD - Financials Comparison

This section allows you to compare key financial metrics between BAWAG Group AG and ResMed Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Please note, different currencies. 0B2.DE values in EUR, RMD values in USD

Frequently Asked Questions


0B2.DE and RMD have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for 0B2.DE and RMD

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer